The latest people and business news from the past month, all in one place.
ProofPilot announced that its CEO Chris Venezia has been accepted into the Forbes Business Council.
HeartcoR Solutions has hired Michael Jandes as director of IT systems.
M3 Wake Research appointed Lucian Cappoli to serve as Head of Early Development and Phase I Operations.
Curavit announced its newest board member, Jackie Kent.
AutoCruitment, LLC appointed Eric Setzer as Chief Financial Officer and Kathy Twiddy appointed as General Counsel & Chief Compliance Officer.
uMotif announced that life science and healthcare executive Adam Deutsch has joined its Board of Directors.
Veeva Systems announced the increasing adoption of Veeva Vault EDC—including six of the top 20 pharma.
3H Medi Solution Inc. has selected THREAD to expand decentralized research capabilities and improve access to clinical research for patients in Japan.
Emmes announced the opening of a new office in Wilmington, North Carolina.
Cognition Health’s commercial clinical research operational processes have undergone a rigorous evidence-based assessment to achieve all seven GCSA quality standards.
Curebase announced it has been named among Y Combinator's 2023 Top Private Companies, placing among the top 6% of all companies that appeared on the list.
Pharma Targeting is celebrating its 10-year anniversary in 2023.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.